Amedeo Smart

Free Medical Literature Service


 

Amedeo

Colorectal Neoplasms

  Free Subscription

Articles published in
J Surg Oncol
    December 2017
  1. KOZMAN MA, Fisher OM, Rebolledo BJ, Parikh R, et al
    CEA to peritoneal carcinomatosis index (PCI) ratio is prognostic in patients with colorectal cancer peritoneal carcinomatosis undergoing cytoreduction surgery and intraperitoneal chemotherapy: A retrospective cohort study.
    J Surg Oncol. 2017 Dec 19. doi: 10.1002/jso.24911.
    >> Share

  2. IWAI T, Yamada T, Koizumi M, Shinji S, et al
    Oxaliplatin-induced increase in splenic volume; irreversible change after adjuvant FOLFOX.
    J Surg Oncol. 2017;116:947-953.
    >> Share

    November 2017
  3. CHOI WJ, Moon JH, Min JS, Song YK, et al
    Real-time detection system for tumor localization during minimally invasive surgery for gastric and colon cancer removal: In vivo feasibility study in a swine model.
    J Surg Oncol. 2017 Nov 28. doi: 10.1002/jso.24922.
    >> Share

  4. CHOE EK, Park KJ, Ryoo SB, Moon SH, et al
    The impact of visceral adipose tissue amount on the adequacy of lymph node retrieval in colorectal cancer surgery.
    J Surg Oncol. 2017 Nov 9. doi: 10.1002/jso.24876.
    >> Share

  5. VAN DE PUTTE D, Van Daele E, Willaert W, Pattyn P, et al
    Effect of abdominopelvic sepsis on cancer outcome in patients undergoing sphincter saving surgery for rectal cancer.
    J Surg Oncol. 2017;116:722-729.
    >> Share

    October 2017
  6. JOSHI HM, Keller DS, Chand M
    Utilization of Indocyanine green to demonstrate lymphatic mapping in colon cancer.
    J Surg Oncol. 2017 Oct 29. doi: 10.1002/jso.24795.
    >> Share

  7. MANSO M, Schmelz J, Aloia T
    ERAS-Anticipated outcomes and realistic goals.
    J Surg Oncol. 2017;116:570-577.
    >> Share

    September 2017
  8. SUN X, Wang T, Zhang C, Ning K, et al
    S100A16 is a prognostic marker for colorectal cancer.
    J Surg Oncol. 2017 Sep 6. doi: 10.1002/jso.24822.
    >> Share

  9. SPOLVERATO G, Bagante F, Aldrighetti L, Poultsides GA, et al
    Management and outcomes of patients with recurrent neuroendocrine liver metastasis after curative surgery: An international multi-institutional analysis.
    J Surg Oncol. 2017;116:298-306.
    >> Share

  10. MORIS D, Tsilimigras DI, Chakedis J, Beal EW, et al
    Liver transplantation for unresectable colorectal liver metastases: A systematic review.
    J Surg Oncol. 2017;116:288-297.
    >> Share

  11. SASAKI K, Margonis GA, Andreatos N, Zhang XF, et al
    The prognostic utility of the "Tumor Burden Score" based on preoperative radiographic features of colorectal liver metastases.
    J Surg Oncol. 2017;116:515-523.
    >> Share

    August 2017
  12. MAHAR AL, Compton C, Halabi S, Hess KR, et al
    Personalizing prognosis in colorectal cancer: A systematic review of the quality and nature of clinical prognostic tools for survival outcomes.
    J Surg Oncol. 2017 Aug 2. doi: 10.1002/jso.24774.
    >> Share

  13. SHO S, Court CM, Winograd P, Russell MM, et al
    A prognostic mutation panel for predicting cancer recurrence in stages II and III colorectal cancer.
    J Surg Oncol. 2017 Aug 2. doi: 10.1002/jso.24781.
    >> Share

  14. STROWITZKI MJ, Schmidt T, Keppler U, Ritter AS, et al
    Influence of neoadjuvant chemotherapy on resection of primary colorectal liver metastases: A propensity score analysis.
    J Surg Oncol. 2017;116:149-158.
    >> Share

  15. LEE L, Alie-Cusson F, Dube P, Sideris L, et al
    Postoperative complications affect long-term outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis.
    J Surg Oncol. 2017;116:236-243.
    >> Share

    July 2017
  16. ISOZAKI Y, Yamada S, Kawashiro S, Yasuda S, et al
    Carbon-ion radiotherapy for isolated para-aortic lymph node recurrence from colorectal cancer.
    J Surg Oncol. 2017 Jul 20. doi: 10.1002/jso.24757.
    >> Share

    June 2017
  17. EMILE SH, Elfeki H, Shalaby M, Sakr A, et al
    Sensitivity and specificity of indocyanine green near-infrared fluorescence imaging in detection of metastatic lymph nodes in colorectal cancer: Systematic review and meta-analysis.
    J Surg Oncol. 2017 Jun 1. doi: 10.1002/jso.24701.
    >> Share

  18. TAKAHASHI H, Akyuz M, Aksoy E, Karabulut K, et al
    Local recurrence after laparoscopic radiofrequency ablation of malignant liver tumors: Results of a contemporary series.
    J Surg Oncol. 2017;115:830-834.
    >> Share

  19. ABDELFATAH E, Page A, Sacks J, Pierorazio P, et al
    Postoperative complications following intraoperative radiotherapy in abdominopelvic malignancy: A single institution analysis of 113 consecutive patients.
    J Surg Oncol. 2017;115:883-890.
    >> Share

  20. SUAREZ J, Marin G, Vera R, Colibaseanu D, et al
    Stent placement prior to initiation of chemotherapy in patients with obstructive, nonoperative left sided tumors is associated with fewer stomas.
    J Surg Oncol. 2017;115:856-863.
    >> Share

  21. CHAPMAN BC, Hosokawa P, Henderson W, Paniccia A, et al
    Impact of neoadjuvant chemoradiation on perioperative outcomes in patients with rectal cancer.
    J Surg Oncol. 2017;115:1033-1044.
    >> Share

    May 2017
  22. LANGAN RC, Goldman DA, D'Angelica MI, DeMatteo RP, et al
    Recurrence patterns following irreversible electroporation for hepatic malignancies.
    J Surg Oncol. 2017;115:704-710.
    >> Share

    March 2017
  23. GOMEZ-MILLAN J, Queipo MI, Del Mar Delgado M, Perez-Villa L, et al
    The impact of body mass index and nuclear beta-catenin on survival in locally advanced rectal cancer treated with preoperative radiochemotherapy.
    J Surg Oncol. 2017;115:301-306.
    >> Share

  24. IMAI K, Castro Benitez C, Allard MA, Vibert E, et al
    Potential of a cure in patients with colorectal liver metastases and concomitant extrahepatic disease.
    J Surg Oncol. 2017;115:488-496.
    >> Share

  25. SAXENA A, Valle SJ, Liauw W, Morris DL, et al
    Limited synchronous hepatic resection does not compromise peri-operative outcomes or survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    J Surg Oncol. 2017;115:417-424.
    >> Share

  26. SUN Y, Lin H, Lu X, Huang Y, et al
    A nomogram to predict distant metastasis after neoadjuvant chemoradiotherapy and radical surgery in patients with locally advanced rectal cancer.
    J Surg Oncol. 2017;115:462-469.
    >> Share

  27. CONNELL LC, Boucher TM, Chou JF, Capanu M, et al
    Relevance of CEA and LDH in relation to KRAS status in patients with unresectable colorectal liver metastases.
    J Surg Oncol. 2017;115:480-487.
    >> Share

    February 2017
  28. DOUAIHER J, Ravipati A, Grams B, Chowdhury S, et al
    Colorectal cancer-global burden, trends, and geographical variations.
    J Surg Oncol. 2017 Feb 13. doi: 10.1002/jso.24578.
    >> Share

  29. ARAUJO RL, Riechelmann RP, Fong Y
    Patient selection for the surgical treatment of resectable colorectal liver metastases.
    J Surg Oncol. 2017;115:213-220.
    >> Share

    January 2017
  30. HARAM A, Boland MR, Kelly ME, Bolger JC, et al
    The prognostic value of neutrophil-to-lymphocyte ratio in colorectal cancer: A systematic review.
    J Surg Oncol. 2017 Jan 20. doi: 10.1002/jso.24523.
    >> Share

    December 2016
  31. SASAKI K, Andreatos N, Margonis GA, He J, et al
    The prognostic implications of primary colorectal tumor location on recurrence and overall survival in patients undergoing resection for colorectal liver metastasis.
    J Surg Oncol. 2016;114:803-809.
    >> Share

  32. KOSTNER AH, Kersten C, Lowenmark T, Ydsten KA, et al
    The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C-reactive protein (CRP) is a strong negative prognostic biomarker.
    J Surg Oncol. 2016;114:895-899.
    >> Share

  33. HIROSHIMA Y, Lwin TM, Murakami T, Mawy AA, et al
    Effective fluorescence-guided surgery of liver metastasis using a fluorescent anti-CEA antibody.
    J Surg Oncol. 2016;114:951-958.
    >> Share

  34. HOKUTO D, Nomi T, Yamato I, Yasuda S, et al
    The prognosis of liver resection for patients with four or more colorectal liver metastases has not improved in the era of modern chemotherapy.
    J Surg Oncol. 2016;114:959-965.
    >> Share

    November 2016
  35. FU J, Wu L, Jiang M, Tan Y, et al
    Signet ring cell carcinoma of resectable metastatic colorectal cancer has rare surgical value.
    J Surg Oncol. 2016 Nov 27. doi: 10.1002/jso.24437.
    >> Share

  36. MCINNES MD, Nanji S, Mackillop WJ, Flemming JA, et al
    Utilization of pre-operative imaging for colon cancer: A population-based study.
    J Surg Oncol. 2016 Nov 4. doi: 10.1002/jso.24492.
    >> Share

  37. HU WH, Chen HH, Yen SL, Huang HY, et al
    Increased expression of interleukin-23 associated with progression of colorectal cancer.
    J Surg Oncol. 2016 Nov 3. doi: 10.1002/jso.24505.
    >> Share

  38. BARKHATOV L, Fretland AA, Kazaryan AM, Rosok BI, et al
    Validation of clinical risk scores for laparoscopic liver resections of colorectal liver metastases: A 10-year observed follow-up study.
    J Surg Oncol. 2016;114:757-763.
    >> Share

    October 2016
  39. GOVAERT JA, Govaert MJ, Fiocco M, van Dijk WA, et al
    Hospital costs of colorectal cancer surgery for the oldest old: A Dutch population-based study.
    J Surg Oncol. 2016 Oct 25. doi: 10.1002/jso.24428.
    >> Share

  40. KIM JC
    A universal port design for the da Vinci Xi(R) system allowing access to the entire colon for colorectal cancer surgery.
    J Surg Oncol. 2016 Oct 6. doi: 10.1002/jso.24468.
    >> Share

  41. HONDA M, Akiyoshi T, Noma H, Ogura A, et al
    Patient-centered outcomes to decide treatment strategy for patients with low rectal cancer.
    J Surg Oncol. 2016;114:630-636.
    >> Share

  42. SOUADKA A, Majbar MA, Raiss M
    Can we rely on the adequate mesorectum excision and the complete pathological response in case of rectal signet-ring cell carcinoma?
    J Surg Oncol. 2016;114:649.
    >> Share

  43. PATEL SV, Roxburgh CS, Vakiani E, Shia J, et al
    Distance to the anal verge is associated with pathologic complete response to neoadjuvant therapy in locally advanced rectal cancer.
    J Surg Oncol. 2016;114:637-641.
    >> Share

  44. GRAVANTE G, Hemingway D, Stephenson JA, Sharpe D, et al
    Rectal cancers with microscopic circumferential resection margin involvement (R1 resections): Survivals, patterns of recurrence, and prognostic factors.
    J Surg Oncol. 2016;114:642-648.
    >> Share

  45. LINO-SILVA LS, Garcia-Gomez MA, Salcedo-Hernandez RA
    In response: Can we rely on the adequate mesorectum excision and the complete pathological response in case of rectal signet-ring cell carcinoma.
    J Surg Oncol. 2016;114:650.
    >> Share

    September 2016
  46. HASKINS IN, Fleshman JW, Amdur RL, Agarwal S, et al
    The impact of bowel preparation on the severity of anastomotic leak in colon cancer patients.
    J Surg Oncol. 2016 Sep 16. doi: 10.1002/jso.24426.
    >> Share

  47. DHIR M, Zenati MS, Padussis JC, Jones HL, et al
    Robotic assisted placement of hepatic artery infusion pump is a safe and feasible approach.
    J Surg Oncol. 2016;114:342-7.
    >> Share

  48. DOUMOURAS AG, Tsao MW, Saleh F, Hong D, et al
    A population-based comparison of 30-day readmission after surgery for colon and rectal cancer: How are they different?
    J Surg Oncol. 2016;114:354-60.
    >> Share

  49. MARGONIS GA, Kim Y, Sasaki K, Samaha M, et al
    Activating KRAS mutation is prognostic only among patients who receive preoperative chemotherapy before resection of colorectal liver metastases.
    J Surg Oncol. 2016;114:361-7.
    >> Share

  50. LIBERALE G, Galdon MG, Moreau M, Vankerckhove S, et al
    Ex vivo detection of tumoral lymph nodes of colorectal origin with fluorescence imaging after intraoperative intravenous injection of indocyanine green.
    J Surg Oncol. 2016;114:348-53.
    >> Share

  51. MASSARWEH NN, Artinyan A, Chang GJ
    Neoadjuvant treatment for rectal cancer-A value-based proposition.
    J Surg Oncol. 2016;114:304-10.
    >> Share

    August 2016
  52. CERCEK A, Boucher TM, Gluskin JS, Aguilo A, et al
    Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapies.
    J Surg Oncol. 2016 Aug 26. doi: 10.1002/jso.24399.
    >> Share

  53. FROYSNES IS, Larsen SG, Spasojevic M, Dueland S, et al
    Complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastasis in Norway: Prognostic factors and oncologic outcome in a national patient cohort.
    J Surg Oncol. 2016;114:222-7.
    >> Share

    July 2016
  54. GRAVANTE G, Miah A, Mann CD, Stephenson JA, et al
    Circumferential resection margins and perineal complications after neoadjuvant long-course chemoradiotherapy followed by extralevator abdominoperineal excision of the rectum: Five years of activity at a single institution.
    J Surg Oncol. 2016;114:86-90.
    >> Share

    June 2016
  55. OKUGAWA Y, Toiyama Y, Mohri Y, Tanaka K, et al
    Elevated serum concentration of monocyte chemotactic protein 4 (MCP-4) as a novel non-invasive prognostic and predictive biomarker for detection of metastasis in colorectal cancer.
    J Surg Oncol. 2016 Jun 28. doi: 10.1002/jso.24335.
    >> Share

  56. MA J, Gao Q, Zeng S, Shen H, et al
    Knockdown of NDRG1 promote epithelial-mesenchymal transition of colorectal cancer via NF-kappaB signaling.
    J Surg Oncol. 2016 Jun 23. doi: 10.1002/jso.24348.
    >> Share

  57. TOKODAI K, Narimatsu H, Nishida A, Takaya K, et al
    Risk factors for recurrence in stage II/III colorectal cancer patients treated with curative surgery: The impact of postoperative tumor markers and an infiltrative growth pattern.
    J Surg Oncol. 2016 Jun 6. doi: 10.1002/jso.24320.
    >> Share

    May 2016
  58. PARK BK, Park JW, Han EC, Ryoo SB, et al
    Systemic inflammatory markers as prognostic factors in stage IIA colorectal cancer.
    J Surg Oncol. 2016 May 24. doi: 10.1002/jso.24299.
    >> Share

  59. COSTI R, Santi C, Bottarelli L, Azzoni C, et al
    Anastomotic recurrence of colon cancer: Genetic analysis challenges the widely held theories of cancerous cells' intraluminal implantation and metachronous carcinogenesis.
    J Surg Oncol. 2016 May 9. doi: 10.1002/jso.24282.
    >> Share

  60. KIM CH, Lee SY, Kim HR, Kim YJ, et al
    Pathologic stage following preoperative chemoradiotherapy underestimates the risk of developing distant metastasis in rectal cancer: A comparison to staging without preoperative chemoradiotherapy.
    J Surg Oncol. 2016;113:692-9.
    >> Share

  61. SILVESTRINI N, Coppola A, Ardito F, Nuzzo G, et al
    Anatomical liver resection of segment 4a en bloc with the caudate lobe.
    J Surg Oncol. 2016;113:665-7.
    >> Share

    April 2016
  62. SMITH JD, Lowery MA, Fell D, Gallagher DJ, et al
    Young patients with synchronous colorectal liver metastases.
    J Surg Oncol. 2016;113:473-6.
    >> Share

  63. NACHMANY I, Pencovich N, Zohar N, Goykhman Y, et al
    Resection of colorectal liver metastases in the elderly-Is it justified?
    J Surg Oncol. 2016;113:485-8.
    >> Share

    March 2016
  64. TAKAMOTO T, Sugawara Y, Hashimoto T, Shimada K, et al
    Dynamic assessment of carcinoembryonic antigen in the first month after liver resection for colorectal liver metastases as a rapid-recurrence predictor.
    J Surg Oncol. 2016;113:463-8.
    >> Share

  65. MUKKAI KRISHNAMURTY D, Wise PE
    Importance of surgical margins in rectal cancer.
    J Surg Oncol. 2016;113:323-32.
    >> Share

  66. BHUTIANI N, Philips P, Martin RC 2nd, Scoggins CR, et al
    Impact of surgical margin clearance for resection of secondary hepatic malignancies.
    J Surg Oncol. 2016;113:289-95.
    >> Share

    February 2016
  67. LYON TD, Turner Ii RM, Nikonow TN, Wang L, et al
    Effect of a concomitant urologic procedure on outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
    J Surg Oncol. 2016;113:218-22.
    >> Share

  68. AKYUZ M, Yazici P, Yigitbas H, Dural C, et al
    Oncologic results of laparoscopic liver resection for malignant liver tumors.
    J Surg Oncol. 2016;113:127-9.
    >> Share

  69. KOSKENVUO L, Peltomaki P, Renkonen-Sinisalo L, Gylling A, et al
    Desmoid tumor patients carry an elevated risk of familial adenomatous polyposis.
    J Surg Oncol. 2016;113:209-12.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016